Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:51 pm Sale | 13G | APTOSE BIOSCIENCES INC NO APTO | Nantahala Capital Management LLC | 120,132 1.5% | -5,932,735 (-98.02%) | View |
| 2024-02-02 6:05 pm Purchase | 13D | APTOSE BIOSCIENCES INC NO APTO | Hanmi Pharmaceutical Co. Ltd. | 2,989,415 22.17% | 2,105,263 (+238.11%) | View |
| 2023-09-11 6:23 pm Purchase | 13D | APTOSE BIOSCIENCES INC NO APTO | Hanmi Pharmaceutical Co. Ltd. | 884,152 12.07% | 884,152 (New Position) | View |
| 2023-02-14 4:56 pm Sale | 13G | APTOSE BIOSCIENCES INC NO APTO | Nantahala Capital Management LLC | 6,052,867 6.6% | -1,551,826 (-20.41%) | View |
| 2023-01-17 06:05 am Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | Fletcher Aaron G.L. | 6,246,788 6.77% | 6,246,788 (New Position) | View |
| 2022-02-14 08:03 am Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | Nantahala Capital Management LLC | 7,604,693 8.5% | 332,020 (+4.57%) | View |
| 2022-02-11 4:15 pm Sale | 13G | APTOSE BIOSCIENCES INC NO APTO | ORBIMED CAPITAL LLC | 0 0% | -8,030,000 (Position Closed) | View |
| 2021-08-09 8:00 pm Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | Wilson Donald R. Jr. | 8,892,437 9.997% | 916,261 (+11.49%) | View |
| 2021-02-17 3:05 pm Sale | 13G | APTOSE BIOSCIENCES INC NO APTO | Consonance Capital Management LP | 0 0% | -6,058,505 (Position Closed) | View |
| 2021-02-16 4:09 pm Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | Consonance Capital Management LP | 6,058,505 11% | 6,058,505 (New Position) | View |
| 2021-02-16 2:37 pm Sale | 13G | APTOSE BIOSCIENCES INC NO APTO | Consonance Capital Management LP | 0 0% | -4,772,190 (Position Closed) | View |
| 2021-02-12 4:42 pm Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | ORBIMED CAPITAL LLC | 8,030,000 9.04% | 8,030,000 (New Position) | View |
| 2021-02-12 3:25 pm Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | Nantahala Capital Management LLC | 7,272,673 8.2% | 1,218,843 (+20.13%) | View |
| 2021-02-01 4:31 pm Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | Wilson Donald R. Jr. | 7,976,176 8.98% | 5,503,041 (+222.51%) | View |
| 2021-01-15 10:54 am Sale | 13G | APTOSE BIOSCIENCES INC NO APTO | Abramson Herbert | 3,687,000 4.1% | -423,000 (-10.29%) | View |
| 2020-02-14 12:34 pm Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | Consonance Capital Management LP | 4,772,190 6.27% | 4,772,190 (New Position) | View |
| 2020-02-14 12:18 pm Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | Nantahala Capital Management LLC | 6,053,830 8% | 6,053,830 (New Position) | View |
| 2020-02-04 10:49 am Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | Abramson Herbert | 4,110,000 5.6% | 393,000 (+10.57%) | View |
| 2019-12-27 4:30 pm Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | Opaleye Management Inc. | 4,085,000 5.52% | 4,085,000 (New Position) | View |